Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 65862-043

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 65862-043). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label- Principal Display Panel (10 mg/12.5 mg (30 Tablet Bottle))

Label for Lisinopril and Hydrochlorothiazide Tablets USP 10 mg/12.5 mg manufactured by Aurobindo Pharma Limited. The label states the product is Rx only and contains 30 tablets. It includes NDC code 65862-043-30, active ingredients with strengths, storage instructions, distributor information (Aurobindo Pharma USA, Inc.), and a barcode. Made in India is noted.*

FDA Label Image

Package Label- Principal Display Panel (20 mg/12.5 mg (30 Tablet Bottle))

Packaging label for Lisinopril and Hydrochlorothiazide Tablets, USP 20 mg/12.5 mg by Aurobindo Pharma Limited. The label specifies each tablet contains Lisinopril USP 20 mg and Hydrochlorothiazide USP 12.5 mg. The package contains 30 tablets and includes storage instructions and distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label- Principal Display Panel (20 mg/25 mg (30 Tablet Bottle))

Label for Lisinopril and Hydrochlorothiazide Tablets USP, 20 mg/25 mg strength, containing 30 tablets. The label indicates prescription use only and lists the active ingredients per tablet: Lisinopril USP 20 mg and Hydrochlorothiazide USP 25 mg. Distributed by Aurobindo Pharma USA, Inc., made in India. Storage instructions and a barcode are also present.*

FDA Label Image

Lisinohydro-str1 (Lisinohydro Str1)

Chemical structure of Lisinopril, an active ingredient in the product Lisinopril and Hydrochlorothiazide. The diagram shows the molecular formula including rings and functional groups characteristic of Lisinopril.*

FDA Label Image

Lisinohydro-str2 (Lisinohydro Str2)

Chemical structure diagram depicting the molecular arrangement of the active ingredient shown in the image, which includes functional groups such as sulfonamide and chlorine substituents attached to a bicyclic ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.